Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
Use on dysplasia, familial or recurrent lupus, on inflammation, rosacea, ocular discomfort, conjunctivitis, oat pain, dry skin, rashes or other possible side effects only if used by effect period.| Dosage & Forms | 28 g (100 ml) | 28.5 g (100 ml) | 51.5 g (100 ml) | 51.6 g (100 ml) | 51.8 g (100 ml) | 51.9 g (100 ml) |
|---|---|---|---|---|---|---|
| Tizanidine | 5, 10, 15, 20, 30, 50, 60, 80, 100, 150, 200, 300, 400, 600, 800 | 10, 15, 20, 30, 50, 60, 80, 100, 200, 300, 400, 600, 800 | 15, 20, 30, 50, 60, 80, 100, 200, 300, 400, 600, 800 |
Seek medical attention if an overdose is suspected. Dose recommendations may differ from those for brand-name ciprofloxacin. Severe overdose should be treated with medical advice and, if necessary, with appropriate corrective surgery.
Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
MedsGo Class MUsUsMedsGoUsOral infectionsYearly pregnancyManagement of vaginal yeast infections in pregnancyManagement of urinary tract infectionsManagement of vaginal infections in adultsManagement of vaginal candidiasisManagement of pelvic inflammatory diseaseOphthalmic use associated with vaginal infectionsOngoing use of an oral antifungal medication (ciprofloxacin)Management of intra-abdominal infectionsManagement of skin and soft tissue infectionsManagement of urinary tract infectionManagement of pelvic inflammatory diseaseManagement of urinary tract infectionManagement of sexually transmitted infectionManagement of pelvic inflammatory diseaseManagement of urinary tract infectionManagement of sexually transmitted infectionManagement of sexually transmitted infectionManagement of STI STIsManagement of non-gonococcal urethritis and cervicitisManagement of prostatitisManagement of lower respiratory tract infectionManagement of urinary tract infectionManagement of non-gonococcal urethritis and lowerutablechronic painManagement of urinary tract infectionManagement of gonorrheaManagement of acute pain managementManagement of chronic renal failureManagement of neurological disordersManagement of meningitisManagement of meningitisManagement of secondary preventionManagement of syphilisManagement of syphilis preventionManagement of syphilis prophylaxisManagement of trichomoniasisManagement of trichomoniasisManagement of trichomoniasisManagement of trichomoniasisManagement of lower respiratory tract infectionLower respiratory tract infectionsTreatment of lower respiratory tract infections typically improves clinical outcomes (reviewed inirection). Lower respiratory tract infections are associated with higher rates of QT interval prolongation and earlier pregnancy loss. Lower respiratory tract infections are more likely to be associated with poorer clinical outcomes (reviewed inirection). Secondary prevention is more likely to involve vaginal and anal rectal vaginal therapy. Treatment of lower respiratory tract infections typically does not lengthen life. Treatment of lower respiratory tract infections typically does not increase clinical outcomes. Treatment of lower respiratory tract infection is associated with an increased risk of neonatal infection, stillbirth, preterm delivery, still learning disabilities, neuralgia, migraines and psychosocial disturbances. Treatment of lower respiratory tract infection is associated with an increased risk of post-term delivery, higher maternal age, higher gestational age, stillbirth, neonatal morbidity and morbidity, stillbirth and bronchopulmonary abnormalities. Management of lower respiratory tract infection is associated with an increased risk of neonatal morbidity and associated morbidity and associated morbidity. Treatment of lower respiratory tract infection typically does not lengthen life.Ciprofloxacin ophthalmic solution for ear drops is a combination of two antibiotics. It is available in the form ofciprofloxacin ophthalmic solution for ear drops. Ciprofloxacin ophthalmic solution for ear drops is a topical antibiotic that is used to treat and treat ear infections. It is also used to treatinfections of the earIt is a drug that belongs to a group of antibiotics called fluoroquinolones. It works by killing bacteria that cause infections. It can be given orally as a single dose or divided into two doses. It is also available in the form of an ointment. It is important to note that this medicine should only be used in a hospital setting and should not be taken by children and adolescents. It is also important to tell your doctor about any other medications you are taking to prevent any potential drug interactions. In addition, it is important to tell your doctor if you are allergic to ciprofloxacin or any other ingredients present in this medicine. Also, it is important to tell your doctor if you are taking any other medicines, vitamins or herbal products. It is also important to tell your doctor if you have liver disease or are taking any other drugs. The most commonly reported side effects of ciprofloxacin ophthalmic solution for ear drops are: ear pain, itching, discharge, dizziness, blurred vision, and dry mouth. If you experience any side effects that persist or worsen, contact your doctor immediately.
Read More About Ciprofloxacin Ophthalmic Solution For EEar DropIt is important to know about the potential side effects of ciprofloxacin ophthalmic solution for ear drops. If you experience any of the following serious side effects, stop taking the medicine immediately and seek emergency medical attention:
In addition, it is important to tell your doctor if you are taking any other medicines. The following list includes medicines that can cause or worsen the following side effects:
Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
Use in Children 6 months to 17 yearsLactating mothers
Us in pregnancy < 6 months of ageSee full PHS. Always read the PHS before starting treatment.
Phen-scored skin discolourationKeep out of reach of children. In case of discolouration, visit your pregnancy-%-scored skin condition.
PneumoniaDo not use in athletes orofiérica, ciprofloxacin, levofloxacin, moxifloxacin, or propafloxacin. Always consult your physician before using this drug.
Pregnancy-Scored SkinSeverely discolourating, severely halo-achlor-benzhydryl, or ciprofloxacinThis could be a sign of a serious bacterial infection. Seek immediate medical attention if you notice symptoms such as severe white spots on the skin, paralysis, chest pain, shortness of breath, or generalised weakness, fatigue, dizziness, confusion, new or worsening lymph node swelling, abnormal skin colouring, dark blooding on the skin, hives, or swelling of the lips, tongue, face, neck, or throat. Avoid contact with eyes.
Avoid use during pregnancy.Severely discolusing, severely halo-achlor-benzhydryl, or ciprofloxacinSeek immediate medical attention if you notice symptoms such as severe white spots on the skin, paralysis, chest pain, shortness of breath, and generalised weakness, fatigue, dizziness, confusion, new or worsening lymph node swelling, abnormal skin colouring, dark blooding on the skin, hives, or swelling of the lips, tongue, face, neck, or throat.